“Remember the p value is based on the difference between baseline and end of trial. With lower disease severity you would of course have a smaller difference and that could be why 350mg beat 700mg. It would also explain the vast difference in chemistry and serum markers between 350mg and 700mg.”

Excellent point.

I hadn’t considered that at all. But of course, you knew that…wink, wink.

Read More: https://investorshangout.com/post/view?id=642...z7X9z6hxws